The device enables low-pressure, gradual dilation of the maxillary sinus ostia, which is intended to help patients tolerate the procedure in an office setting under local anesthesia.
The Vent-Os system has also received the CE Mark, Health Canada license and Australian Therapeutic Goods Administration Certificate.
More Articles on Supply Chain:
Reducing Supply Chain Costs
First Navio Unicondylar Knee Replacement Performed in France
Abrams Royal Pharmacy Issues Voluntary Recall on All Unexpired Sterile Products
